GLP-1 antibodies are immunoreagents designed to detect, quantify, or modulate the activity of GLP-1, a 30–31 amino acid peptide hormone involved in glucose homeostasis, insulin secretion, and immune regulation . These antibodies target either the GLP-1 peptide itself or its receptor (GLP-1R), a class B G protein-coupled receptor (GPCR) .
Recent advancements in antibody engineering have yielded both antagonistic and agonistic GLP-1R antibodies:
TB-222-023: A high-potency antagonist derived from phage display libraries, showing 10-fold greater inhibition of cAMP accumulation compared to exendin-(9-39), a traditional GLP-1R antagonist .
TAO Algorithm: Twist Antibody Optimization enabled the generation of 444 HCDR3 mutations, leading to improved binding affinity and functional specificity .
Insulin Secretion: GLP-1 antibodies like TB-222-023 reduce glucose-dependent insulin secretion in pancreatic β-cells .
β-Cell Protection: Antibodies mimicking GLP-1 activity enhance β-cell proliferation and inhibit apoptosis .
Macrophage Polarization: GLP-1 analogues (e.g., exenatide, lixisenatide) promote M2 macrophage polarization, reducing inflammation in atherosclerosis and metabolic disorders .
Intestinal Immunity: GLP-1R activation in intestinal epithelial lymphocytes (IELs) suppresses pro-inflammatory cytokine production .
GLP-1R antagonists like TB-222-023 lower insulin secretion in pancreatic islets, offering therapeutic potential for HI .
GLP-1R agonists reduce neuroinflammation and improve outcomes in Alzheimer’s and Parkinson’s disease models .
Cardiovascular benefits include plaque stabilization and blood pressure regulation .
Short Half-Life: Endogenous GLP-1 has a 2-minute half-life due to DPP-4 cleavage, necessitating engineered antibodies for sustained activity .
Tissue-Specific Effects: Off-target activation in non-pancreatic tissues (e.g., brain, kidneys) requires precise targeting .
KEGG: sce:YLL057C
STRING: 4932.YLL057C
JLP1 (Q12358) is a protein found in Saccharomyces cerevisiae (Baker's yeast). It functions primarily in cellular processes specific to yeast metabolism. While detailed functional characterization is still evolving in current research, it belongs to a family of proteins that may be involved in stress responses and cellular adaptation mechanisms. Studies investigating JLP1 typically use antibody-based detection methods to elucidate its expression patterns under various experimental conditions.
The JLP1 antibody (CSB-PA622466XA01SVG) is a rabbit polyclonal antibody raised against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) JLP1 protein. It has been validated for ELISA and Western blot applications. The antibody is purified using Protein A/G methodology, which provides high specificity for the target protein . The corresponding JLP1 gene has an Entrez Gene ID of 850669 and UniProt accession number Q12358 .
Based on supplier validation data, JLP1 antibody is suitable for both ELISA and Western blot applications . For Western blotting, researchers should follow standard protocols incorporating appropriate blocking agents and detection systems compatible with rabbit-derived antibodies. ELISA applications can utilize either direct or sandwich formats, leveraging the polyclonal nature of the antibody to capture multiple epitopes of the JLP1 protein.
A methodologically sound Western blot protocol for JLP1 detection includes:
Sample preparation: Lyse yeast cells in buffer containing protease inhibitors
Protein separation: Run 20-50 μg total protein on SDS-PAGE (10-12%)
Transfer: Use PVDF membrane with standard transfer buffer
Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature
Primary antibody: Dilute JLP1 antibody 1:1000 in blocking buffer; incubate overnight at 4°C
Washing: 3-5 washes with TBST, 5-10 minutes each
Secondary antibody: Anti-rabbit HRP conjugate (1:5000); incubate 1 hour at room temperature
Detection: Use ECL substrate and image according to standard protocols
Include appropriate positive controls using the recombinant immunogen protein provided with the antibody package .
Rigorous antibody validation should include:
Positive control: Use the supplied recombinant immunogen protein (200 μg provided in antibody package)
Negative control: Utilize pre-immune serum (1 ml provided) to establish background signal levels
Knockdown/knockout validation: Compare antibody signal in wild-type vs. JLP1 knockout yeast strains
Cross-reactivity assessment: Test antibody against related yeast proteins
Peptide competition: Pre-incubate antibody with purified JLP1 protein to block specific binding
Methodical validation establishes confidence in experimental results and addresses potential specificity concerns that might compromise data interpretation.
For effective JLP1 detection from yeast samples:
Culture conditions: Standardize growth phase and media composition
Cell disruption: Use glass bead lysis in buffer containing:
50 mM Tris-HCl, pH 7.5
150 mM NaCl
1% Triton X-100
1 mM EDTA
Protease inhibitor cocktail
Centrifugation: 13,000 × g for 15 minutes at 4°C to remove cell debris
Protein quantification: Bradford or BCA assay
Sample handling: Add reducing agent (DTT or β-mercaptoethanol) to samples immediately before denaturation
Denaturation: Heat samples at 95°C for 5 minutes in Laemmli buffer
Consistency in sample preparation is crucial for reproducible results when studying JLP1 expression under different experimental conditions.
For effective immunoprecipitation of JLP1:
Pre-clear lysate: Incubate with Protein A/G beads (1 hour at 4°C)
Antibody binding: Add 2-5 μg JLP1 antibody to 500 μg protein lysate; incubate overnight at 4°C
Capture: Add 40 μl Protein A/G beads; incubate 2-4 hours at 4°C
Washing: 4-5 washes with IP buffer containing reduced detergent
Elution: SDS sample buffer at 95°C for 5 minutes
Analysis: Western blot with a different JLP1 antibody or mass spectrometry
This approach enables studies of JLP1 protein interactions and post-translational modifications in different physiological conditions.
Multiple complementary approaches can elucidate JLP1 interaction networks:
Co-immunoprecipitation: Use JLP1 antibody to pull down protein complexes for mass spectrometry analysis
Proximity labeling: Express JLP1 fused to BioID or APEX2 for capturing proximal proteins
Yeast two-hybrid screening: Use JLP1 as bait to identify potential interaction partners
Cross-linking mass spectrometry: Capture transient interactions through chemical cross-linking
Fluorescence resonance energy transfer (FRET): Monitor direct protein interactions in live cells
Combining these methodologies provides robust validation of interaction partners and insights into JLP1 function within cellular pathways.
For accurate subcellular localization determination:
Immunofluorescence:
Fix yeast cells with 4% paraformaldehyde
Permeabilize with zymolyase followed by 0.1% Triton X-100
Block with 3% BSA in PBS
Incubate with JLP1 antibody (1:200 dilution)
Use fluorophore-conjugated secondary antibody
Include markers for cellular compartments (ER, mitochondria, nucleus)
Subcellular fractionation:
Separate cellular compartments by differential centrifugation
Analyze fractions by Western blot using JLP1 antibody
Include compartment-specific marker proteins as controls
Live cell imaging:
Generate strains expressing JLP1-GFP fusion proteins
Validate fusion protein functionality
Monitor localization under various stress conditions
These approaches provide complementary data on JLP1 localization patterns and potential translocation events.
Non-specific binding can be mitigated through systematic optimization:
Increase blocking stringency: Use 5% BSA instead of milk; add 0.1-0.3% Tween-20
Optimize antibody concentration: Perform titration experiments (1:500 to 1:5000)
Modify washing conditions: Increase wash buffer stringency with higher salt concentration (up to 500 mM NaCl)
Pre-adsorb antibody: Incubate with lysate from JLP1-knockout yeast to remove cross-reactive antibodies
Use alternative blocking agents: Try commercial blocking reagents specifically designed for yeast applications
Careful optimization minimizes background while preserving specific JLP1 signal.
When facing contradictory results:
Verify antibody lot consistency: Different lots may exhibit variable specificity
Confirm protein identity: Perform mass spectrometry on detected bands
Evaluate technique-specific artifacts: Some methods may detect denatured vs. native conformations
Assess post-translational modifications: Different methods may preferentially detect modified forms
Consider cellular context: Expression levels and localization may vary with experimental conditions
Validate with orthogonal approaches: Use JLP1 tagging or quantitative PCR to confirm protein expression patterns
Systematic investigation of discrepancies often reveals important biological insights about protein behavior under different experimental conditions.
Rigorous experimental design requires:
Loading controls: Use constitutively expressed proteins (e.g., actin, GAPDH) to normalize expression
Time course controls: Monitor expression at multiple time points to capture transient changes
Dose-response analysis: Evaluate multiple stress intensities to establish threshold responses
Strain controls: Compare wild-type with regulatory mutants affecting stress response pathways
Genetic validation: Confirm antibody specificity using JLP1 deletion strains
Cross-stress analysis: Compare responses across different stressors to identify specific vs. general responses
These controls establish causality between stress conditions and observed JLP1 expression changes.
For chromatin immunoprecipitation (ChIP) applications:
Cross-linking: Treat yeast cells with 1% formaldehyde for 10-15 minutes
Chromatin preparation: Lyse cells and sonicate to generate 200-500 bp DNA fragments
Immunoprecipitation: Use 5-10 μg JLP1 antibody with Protein A/G beads
Washing: Use increasingly stringent buffers to remove non-specific interactions
Reverse cross-linking: Incubate samples at 65°C overnight
DNA purification: Extract DNA for PCR or sequencing analysis
Controls: Include input DNA, IgG control, and positive control for known DNA-binding proteins
This approach can identify potential DNA-binding activities or chromatin associations of JLP1 in yeast.
To investigate JLP1 post-translational modifications:
Phosphorylation analysis:
Immunoprecipitate JLP1 using the specific antibody
Detect phosphorylation using phospho-specific antibodies or Phos-tag gels
Confirm with mass spectrometry to identify specific modified residues
Ubiquitination studies:
Co-immunoprecipitate with anti-ubiquitin and anti-JLP1 antibodies
Use deubiquitinase inhibitors during sample preparation
Detect ubiquitinated forms via Western blot
Glycosylation assessment:
Treat samples with glycosidases before Western blotting
Use lectin-based affinity purification coupled with JLP1 immunodetection
Quantification of modification stoichiometry provides insights into regulatory mechanisms affecting JLP1 function.
To explore potential roles in protein quality control:
Stress induction experiments:
Expose yeast to protein-misfolding stressors (heat shock, tunicamycin, DTT)
Monitor JLP1 expression and localization changes using the antibody
Correlate with unfolded protein response markers
Genetic interaction studies:
Create double mutants with known quality control genes
Assess synthetic phenotypes under stress conditions
Use JLP1 antibody to monitor protein levels in different genetic backgrounds
Proteasome inhibition:
Treat cells with MG132 or bortezomib
Monitor JLP1 levels and modification state
Assess co-localization with accumulated ubiquitinated proteins
These approaches can reveal functional connections between JLP1 and cellular protein quality control mechanisms.
For detecting low-abundance JLP1:
Enhanced chemiluminescence (ECL):
Use high-sensitivity ECL substrates
Optimize exposure times with incremental imaging
Consider signal accumulation with multiple exposures
Fluorescent detection:
Use near-infrared fluorescent secondary antibodies
Leverage multi-channel detection for simultaneous imaging of controls
Quantify signals using calibrated imaging systems
Amplification systems:
Employ tyramide signal amplification
Use biotin-streptavidin systems to enhance signal
Consider polymer-based detection systems for signal enhancement
Selecting the appropriate detection system based on expected expression levels ensures reliable JLP1 quantification.
Robust statistical analysis requires:
Experimental design:
Perform at least three biological replicates
Include technical replicates for Western blot and ELISA
Standardize sample preparation and loading
Quantification methods:
Use densitometry software with background subtraction
Normalize to appropriate loading controls
Generate standard curves for absolute quantification
Statistical testing:
Apply appropriate tests based on data distribution (parametric vs. non-parametric)
Account for multiple comparisons when analyzing multiple conditions
Report effect sizes along with p-values
Data presentation:
Include representative blot images alongside quantification
Present normalized data with appropriate error bars
Indicate sample sizes and statistical significance levels